Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Great Place to Work® and Fortune magazine selected Rockwell Medical for the 2025 Fortune Best Workplaces in Manufacturing and ProductionTM List in the small & medium category for the second year in a row.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023053731/en/
Rockwell Medical Named Fortune 'Best Workplaces in Manufacturing & Production' Second Year in a Row
The Fortune 'Best Workplaces in Manufacturing & Production' list recognizes companies for their exceptional workplace culture determined by employee feedback on their experiences with management, colleagues, and the Company's values.
"Being recognized as a one of the best workplaces in manufacturing and production by Fortune is especially meaningful because it reflects the sentiment of our employees," said Lesley Spriggs, Vice President of Human Resources at Rockwell Medical. "Our improved ranking on this year's list reflects the positive culture we have built and continue to foster together—one grounded in respect, collaboration, inclusivity, and shared purpose. Our team’s hard work and dedication are what make Rockwell Medical not only a leader in our industry, but also an exceptional place to build a career. We are proud of this achievement and even more proud of the people who made it possible.”
About Rockwell Medical
Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work® in 2023, 2024 and 2025, and named Fortune Best Workplaces in Manufacturing & Production™ in 2024 and 2025, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions™. For more information, visit www.rockwellmed.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251023053731/en/
$RMTI named @GPTW_US @fortune 'Best Workplaces in Manufacturing & Production' 2nd Year in a Row #GreatPlaceToWork #BestWorkplaces
Contacts
Heather R. Hunter
(248) 432-1362
IR@RockwellMed.com